icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics of simeprevir (TMC435) in volunteers with moderate or severe hepatic impairment
 
 
  Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
 
Sivi Ouwerkerk-Mahadevan,1 Alexandru Simion,2 Kurt Spittaels,2 Maria
Beumont-Mauviel2
1Janssen Research and Development, Beerse, Belgium; 2Janssen Infectious Diseases BVBA, Beerse, Belgium

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif